Organogenesis Holdings Inc. ORGO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.16M-182% | $43.7M+470% | $21.57M+74.9% | -$9.39M+44.9% | -$18.84M-797% | ||
| $4.17M+21.2% | $4.07M+12.5% | $4.03M+12.9% | $3.73M+10.9% | $3.44M+12.1% | ||
| $3.64M+8.0% | $4.32M+49.6% | $3.07M+13.0% | $2.54M-1.0% | $3.37M+39.9% | ||
| -$15.37M-1,114% | $15.63M+652% | -$3.84M-74.6% | -$1.03M— | -$1.27M— | ||
| —— | -$115K+83.5% | -$29K-190% | -$25K+71.3% | -$19K+94.5% | ||
| -$104.5M-1,744% | $51.48M+485% | $50.69M— | $19.31M+77.7% | -$5.67M-137% | ||
| $8.73M0.0% | $2.96M+551% | $0-100% | $7.16M— | $8.73M+87.0% | ||
| -$2M+19.8% | -$1.17M— | -$994K+74.3% | $4.13M— | -$2.5M+43.2% | ||
| $1.66M-67.7% | —— | —— | $7.82M— | $5.12M+18.7% | ||
| $293K— | —— | $1.43M+5,408% | —— | —— | ||
| $5.71M+578% | $798K-4.3% | $842K+1.0% | $841K+0.8% | $842K-6.5% | ||
| $2.49M+24.6% | $2.15M+9.0% | $2.12M+5.1% | $2.08M-3.7% | $2M-9.4% | ||
| $21.13M+206% | —— | —— | -$32.87M-794% | -$19.94M-96.2% | ||
| $3.15M-13.2% | $4.65M+38.4% | $2.24M-13.0% | $3.64M+93.5% | $3.63M+63.2% | ||
| -$3.15M+13.2% | -$4.65M-38.4% | -$2.24M+13.0% | -$3.64M-93.5% | -$3.63M-63.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2K-99.8% | $130K+3,150% | $0— | $25K-86.1% | ||
| $9.84M+3,353% | $302K+9.0% | $296K+7.2% | $288K+8.3% | $285K+8.8% | ||
| $3.05M+69.9% | $87K+4,250% | $2K— | $0-100% | $1.8M+60.4% | ||
| —— | —— | —— | —— | —— | ||
| -$20.21M-883% | -$4.81M-114% | -$10.21M-509% | -$288K+83.3% | -$2.06M+21.2% | ||
| -$2.23M+91.3% | —— | -$9.36M— | -$36.8M— | -$25.62M-70.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | $1.26M-14.4% | $295K-57.7% | $3.64M-23.5% | $150K+329% | ||
| -$6.99M-88.5% | -$7.39M-218% | -$1.87M-32.2% | -$2.38M-22.0% | -$3.71M-47.5% | ||
| $5.71M+578% | $798K-4.3% | $842K+1.0% | $841K+0.8% | $842K-6.5% | ||
| —— | —— | —— | —— | —— | ||
| -$19.48M-144% | $12.32M+276% | $11.94M— | -$5.89M— | -$7.99M-180% | ||
| $2.4M+17.8% | $2.19M-54.5% | $2.16M-35.6% | $2.11M-43.1% | $2.04M-7.4% | ||
| $1.66M-67.7% | —— | —— | $7.82M— | $5.12M+18.7% | ||
| $91K+31.9% | $167K+106% | $69K-33.7% | $70K-32.7% | $69K-34.3% | ||
| $2.49M+24.6% | $2.15M+9.0% | $2.12M+5.1% | $2.08M-3.7% | $2M-9.4% | ||
| -$3.96M-553% | $2.81M+1,207% | $2.29M+35.2% | $2.24M+111% | $873K-9.8% | ||
| —— | $1.94M— | $922K— | $1.75M— | $6.57M— | ||
| $7.32M+103% | $3.62M— | $3.62M— | $3.62M— | $3.62M— | ||
| $9.84M+3,353% | $302K+9.0% | $296K+7.2% | $288K+8.3% | $285K+8.8% | ||
| —— | —— | —— | —— | —— | ||
| $3M+9.3% | $2.94M+554% | $2.87M+539% | $2.81M+525% | $2.75M+511% | ||
| $39K-77.3% | $2.74M+1,407% | —— | —— | $172K— | ||
| $4.07M— | —— | —— | —— | —— | ||
| —— | $672.75K— | $672.75K— | $672.75K— | $672.75K— | ||
| —— | —— | —— | —— | —— | ||
| $483K— | $19.22M— | —— | —— | —— | ||
| —— | $24.59M+529% | $573K+49.2% | $173K+49.1% | $1.64M+134% | ||
| $17.98M+176% | —— | —— | -$36.51M— | -$23.56M-90.3% | ||
| $17.98M+176% | —— | —— | -$36.51M— | -$23.56M-90.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Organogenesis Holdings Inc. generate?
- Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
- What is Organogenesis Holdings Inc.'s free cash flow?
- After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
- Where does Organogenesis Holdings Inc.'s cash flow data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
